logo

Durect Corp. (DRRX)



Trade DRRX now with
  Date
  Headline
9/23/2020 8:36:00 AM DURECT: First Patient Dosed In Phase 2 Study Of DUR-928 In COVID-19 Patients With Acute Liver Or Kidney Injury
9/22/2020 8:34:41 AM DURECT Announces Study Design For Phase 2b AHFIRM Clinical Trial Of DUR-928 In Severe AH Patients
8/27/2020 8:36:15 AM DURECT Announces Presentation Of Phase 2a Pharmacokinetic Data Of DUR-928 In Alcoholic Hepatitis
7/1/2020 8:46:52 AM DURECT Begins Recruiting Patients For Phase 2 Study On DUR-928 In COVID-19 Patients With Acute Liver Or Kidney Injury
5/26/2020 8:33:17 AM DURECT Announces Positive Topline Data From Phase 1b Study Of DUR-928 In NASH
1/17/2020 6:50:38 AM DURECT Says FDA Committee Voted 6-6 On Safety And Efficacy Of POSIMIR
1/16/2020 7:08:02 AM DURECT Trading Halted Today; FDA Advisory Committee To Discuss POSIMIR For Post-Surgical Analgesia
1/2/2020 9:02:52 AM DURECT Reports Results From Phase 2a Clinical Trial Of DUR-928 In Patients With Mild To Moderate Plaque Psoriasis
11/12/2019 8:50:47 AM DURECT Announces Positive Results From Phase 2a Trial Of DUR-928 In Alcoholic Hepatitis Patients